Cytodyn Inc (CYDY)

[CTMedic]

An illuminating post from Twitter:

kgromax with lowercase o
@kgromax
NO press release from $CYDY - This is bad as, for safety reasons, they know already the total deaths per arm in the COVID CD12 trial - it’s game over

I have no way of knowing if this is the same poster here with a very similar name, but it could be.

Equally negative.

This poster on twitter seems to have difficulty appreciating the structure of a blinded clinical trials.

kgromax (the Twitter poster, maybe the Ihub posted, IDK) states "they know already the total deaths per arm in the COVID CD12 trial"

Oh how I wish that was the case (and that they had told me. I would have put my deposit down on the new Ford Bronco. I have heard that there are 100,000 people ahead of me for the Bronco and the line gets longs every day. Completely unfair).

From the NIH:

.In single- or double-blind studies, the participants don't know which medicine is being used, and they can describe what happens without bias. Blind studies are designed to prevent anyone (doctors, nurses, or patients) from influencing the results. This allows scientifically accurate conclusions. In single-blind ("single-masked") studies, only the patient is not told what is being given. In a double-blind study, only the pharmacist knows; the doctors, nurses, patients, and other health care staff are not informed. If medically necessary, however, it is always possible to find out what the patient is taking.

clinicaltrials.gov website describes CD12 as quadruple masked (blinded).

Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

I searched high and low, but was unable to find any information indicating that in these trials participants, care providers, investigators and outcomes assessors (DSMB & Amarex) will be blinded, but somehow Cytodyn and NP would know to which arm each patient was assigned. That just doesn't seem quite right.

Surely NP would not be given this "extra" consideration, especially after his 1996 $100 overdraft conviction.

I have it on very good authority that Dr. Kelly very well may have had multiple fines for overdue library books, so he should be ruled out as well.

Maybe our source of previously unknown information, Twitter guy @kgromax can help us understand this wholesale change in the structure and security of clinical trials.